- Center East’s first full-scale AI adoption for nationwide screening marks Lunit’s newest milestone amid speedy enlargement of worldwide most cancers screening initiatives
SEOUL, South Korea, July 22, 2024 /PRNewswire/ — Lunit, a number one supplier of AI-powered options for most cancers diagnostics and therapeutics, as we speak introduced the implementation of its AI-powered breast most cancers detection resolution, Lunit INSIGHT MMG, in Qatar’s nationwide breast most cancers screening program. This marks the primary nationwide adoption of AI in a national-level breast screening workflow within the Center East. The partnership, set for an preliminary interval of 5 years, demonstrates a long-term dedication to advancing breast most cancers screening in Qatar.
Beginning June 2024, Qatar’s Main Well being Care Company (PHCC) has built-in Lunit INSIGHT MMG into its “Screen for Life” program, the nation’s nationwide breast and bowel most cancers screening initiative. The AI resolution goals to reinforce early detection of breast most cancers, doubtlessly lowering missed diagnoses and enhancing survival charges in Qatar’s triennial screening program.
“Breast cancer is the most common cancer among women in Qatar, accounting for 32% of all female cancer cases[1],” mentioned Dr. Sheikha Abu Sheikha, Director of Early Detection Packages at PHCC. “To handle this, we’re integrating Lunit’s AI as a crucial second opinion for our radiologists. As the first country in the Middle East to implement AI across the entire screening program, we’re reinforcing Qatar’s commitment to high-quality healthcare for women across the country.”
The implementation follows a profitable retrospective validation section that started in March 2023. Glad with the efficiency and added worth, two radiologists now learn every mammogram whereas referring to Lunit INSIGHT MMG’s outcomes, enhancing accuracy and effectivity within the screening course of.
Lunit’s success in Qatar is a part of a broader pattern of the corporate’s enlargement in business-to-government (B2G) most cancers screening initiatives worldwide. Notable current deployments embody:
- Australia: Supplying Lunit INSIGHT MMG to BreastScreen New South Wales
- Sweden: Delivering Lunit INSIGHT MMG to Capio S:t Göran Hospital, marking the primary occasion the place AI changed one human reader in breast screening
- Kingdom of Saudi Arabia: Offering the Lunit INSIGHT suite to Seha Digital Hospital, connecting over 150 hospitals
- Iceland: Implementing Lunit INSIGHT MMG for nationwide breast screening, the primary European nation to deploy AI for your complete inhabitants
“Our collaboration with Qatar’s PHCC for the ‘Screen for Life’ will equip healthcare providers with a powerful new tool to enhance medical diagnostics,” mentioned Brandon Suh, CEO of Lunit. “As we expand into national screening programs worldwide, we’re enhancing early cancer detection and reshaping preventive care. Each implementation brings us closer to our vision of making AI-assisted cancer screening more accurate and accessible to people around the world, regardless of their location.”
The “Screen for Life” program, applied by Qatar’s PHCC, is a nationwide initiative providing free breast and bowel most cancers screening to eligible residents. This cornerstone of Qatar’s public well being technique goals to advertise early detection by schooling, consciousness, and accessible screening companies.
|
[1] Qatar Most cancers Info Middle: Most cancers Incidence Report 2019
|
About Lunit
Based in 2013, Lunit is a medical AI firm on a mission to beat most cancers. We harness AI-powered medical picture analytics and AI biomarkers to make sure correct analysis and optimum therapy for every most cancers affected person. Our FDA-cleared Lunit INSIGHT suite for most cancers screening serves over 3,000 hospitals and medical establishments throughout 40+ international locations.
Our scientific findings are featured in high journals, together with the Journal of Medical Oncology and the Lancet Digital Well being, and introduced at international conferences such because the ASCO and RSNA.
In 2024, Lunit acquired Volpara Well being Applied sciences, setting the stage for unparalleled synergy and accuracy, notably in breast well being and screening applied sciences.
Headquartered in Seoul, South Korea, with a community of places of work worldwide, Lunit leads the worldwide combat towards most cancers. Uncover extra at lunit.io.
